Back
Extendicare Quote, Financials, Valuation and Earnings
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)
Buy
89
EXE.TO
Extendicare
Last Price:
10.64
Seasonality Move:
5.79%
7 Day Trial
ALL ACCESS PASS
$
7
Better Than Oil Stocks
CLICK HERE TO FIND OUT MOREExtendicare Price Quote
$10.64
Extendicare Key Stats
Buy
89
Extendicare (EXE.TO)
is a Buy
Day range:
$10.45 - $10.67
52-week range:
$6.63 - $10.89
Dividend yield:
4.51%
P/E ratio:
26.60
P/S ratio:
0.73
P/B ratio:
7.81%
Volume:
150.5K
Avg. volume:
168.6K
1-year change:
47.78%
Market cap:
$888.1M
Revenue:
$1.3B
EPS:
$0.73
How Much Does Extendicare Make?
-
How Much Are Extendicare's Sales Annually?
EXE.TO Revenues are $1.3B -
How Much Profit Does Extendicare's Make A Year?
EXE.TO net income is $34M
Is Extendicare Growing As A Company?
-
What Is Extendicare's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.11% -
What Is Extendicare's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0.36%
Extendicare Stock Price Performance
-
Did Extendicare Stock Go Up Last Month?
Extendicare share price went up by 13.07% last month -
Did EXE.TO's Share Price Rise Over The Last Year?
EXE.TO share price rose by 47.78% over the past 1 year
What Is Extendicare 52-Week High & Low?
-
What Is Extendicare’s 52-Week High Share Price?
Extendicare has traded as high as $10.89 over the past 52 weeks -
What Is Extendicare’s 52-Week Low Share Price?
Extendicare has traded as low as $6.63 over the past 52 weeks
Extendicare Price To Free Cash Flow
-
Is Extendicare Stock Overvalued?
Extendicare is trading at a price to free cash flow ratio of 10.86 -
Is Extendicare Stock Undervalued?
Extendicare EV to Free Cash Flow ratio is 10.95 -
What Is Extendicare’s Price Earnings Growth Ratio?
EXE.TO PEG ratio is 0.10 -
Is Extendicare Trading At A Premium To Earnings?
Extendicare EV to EBIT ratio is 9.92
Is It Risky To Buy Extendicare?
-
How Much Debt Does Extendicare Have?
Total long term debt quarterly is $321.7M -
How Much Cash Does Extendicare Have?
Cash and short term investments quarterly total is $154.3M -
What Is Extendicare’s Book Value Per Share?
Book value per share is 1.36
Is Extendicare Cash Flow Positive?
-
What Is EXE.TO Cash Flow From Operations?
Cash flow from operations (TTM) is $145.1M -
What Is Extendicare’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$66.7M -
What Is Extendicare’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$20.3M
Extendicare Return On Invested Capital
-
Is Management Doing A Good Job?
EXE.TO return on invested capital is 14.89% -
What Is Extendicare Return On Assets?
ROA measures how assets are converting to revenues and is 9.14% -
What Is EXE.TO Return On Equity?
ROE is a measure of profitability and is 64.65%
Extendicare Earnings Date & Stock Price
-
What Is Extendicare's Stock Price Today?
A single share of EXE.TO can be purchased today for 10.64 -
What Is Extendicare’s Stock Symbol?
Extendicare trades on the tsx under the ticker symbol: EXE.TO -
When Is Extendicare’s Next Earnings Date?
The next quarterly earnings date for Extendicare is scheduled on March 7, 2025 -
When Is EXE.TO's next ex-dividend date?
Extendicare's next ex-dividend date is November 29, 2024 -
How To Buy Extendicare Stock?
You can buy Extendicare shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Extendicare Competitors
-
Who Are Extendicare's Competitors?
Below is a list of companies who compete with Extendicare or are related in some way:
Extendicare Dividend Yield
-
What Is EXE.TO Dividend Yield?
Extendicare’s dividend yield currently is 4.51% -
What Is Extendicare’s Payout Ratio?
Extendicare’s payout ratio is 62.6% -
When Did Extendicare Last Pay A Dividend?
The latest dividend pay date is December 11, 2024 -
What Is Extendicare’s Dividend Per Share?
Extendicare pays a dividend of $0.12 per share
Extendicare Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 35.71% | 0% |
| Revenue: | 11.33% | -1.55% |
Analyst Recommendations
| Buy Recommendations: | 2 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 10.50 |
| Downside from Last Price: | -1.32% |